Science Explorer Back to mapMap
Discussion
Researcher · Pfizer (United States) · United States

C. Chen

C. Chen publishes mostly in Pulmonary and Respiratory Medicine, Cancer Research and Economics and Econometrics, on topics such as Advanced Breast Cancer Therapies, Renal cell carcinoma treatment and Cancer Genomics and Diagnostics.

OpenAlex
World rank
#2,930,575
of 7,710,434 ranked researchers
Rank in United States
#844,548
of 1,627,098
Works
17
Citations
523
Citations per work
30.8
h-index
5
i10-index 5Top 85% in Pulmonary and Respiratory Medicine
C. Chen

What does C. Chen research?

C. Chen's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (19%), Economics, Econometrics and Finance (11%).

Health Sciences: 7 works · 42.5% of their workMedicine: 7 works · 42.5% of their workPulmonary and Respiratory Medicine: 4 works · 25.5% of their workOncology: 2 works · 10.6% of their workSurgery: 1 works · 6.4% of their workEverything else: 5 works · 27.7% of their workLife Sciences: 3 works · 19.2% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 19.2% of their workCancer Research: 2 works · 12.8% of their workMolecular Biology: 1 works · 6.4% of their workSocial Sciences: 2 works · 10.6% of their workEconomics, Econometrics and Finance: 2 works · 10.6% of their workEconomics and Econometrics: 2 works · 10.6% of their workTHEIR WORKC. Chen17works
Life Sciences19%Health Sciences42%Social Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine742.5%
  2. Everything else527.7%
    1. Biochemistry, Genetics and Molecular Biology319.2%
    1. Economics, Econometrics and Finance210.6%
  1. 1Pulmonary and Respiratory Medicine26% of their works
  2. 2Cancer Research13% of their works
  3. 3Economics and Econometrics11% of their works
  4. 4Oncology11% of their works
  5. 5Molecular Biology6% of their works
  6. 6Surgery6% of their works

Research topics

Which keywords describe C. Chen's research?

The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, Metastatic, CDK4/6 Inhibitors, Palbociclib, Renal Cell Carcinoma, Treatment and Cancer Genomics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Breast Cancer72 topics
  2. Metastatic Breast Cancer72 topics
  3. Metastatic62 topics
  4. CDK4/6 Inhibitors51 topic
  5. Palbociclib51 topic
  6. Renal Cell Carcinoma41 topic
  7. Treatment41 topic
  8. Cancer Genomics31 topic
  9. Cost of Care31 topic
  10. Financial Toxicity31 topic
  11. Mutational Signatures31 topic
  12. Breast Tumours21 topic
  13. Chemotherapy-Induced Peripheral Neuropathy21 topic
  14. Gene Expression21 topic
  15. HER221 topic
  16. Taxanes21 topic
  17. Trastuzumab21 topic
  18. VEGF21 topic
  19. endothelial progenitor cells21 topic

Where does C. Chen work?

C. Chen's main affiliation in the publication record is Pfizer (United States), United States.

How many publications and citations does C. Chen have?

OpenAlex counts 17 works and 523 citations for C. Chen, an h-index of 5, ranking #2,930,575 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named C. Chen

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about C. Chen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.